(%)
As on LastTradeTime IST
| Open | Volume | ||
|---|---|---|---|
| High | Value | ||
| Low | VWAP | ||
| Avg Price | MarketCap | ||
| LTP | 52 week High | ||
| Prev Close | 52 week Low | ||
| Price change | % change |
| Year Ending | 2022-03-31 | Current Reserves | 10976494000 |
|---|---|---|---|
| Current Equity | 95106000 | EPS | |
| Book Value | Beta | 0 | |
| PE | 0 | PB | 0 |
| Dividend Yield | 0 | Market Cap | 70473546000 |
| CompanyName | Concord Biotech Ltd. | Short Name | Concord Biotech Ltd. |
|---|---|---|---|
| Sector | Pharmaceuticals and health care | Industry | Pharmaceuticals |
| Business Group | Herren Group | CINNo | U24230GJ1984PLC007440 |
| Incorporation Date | 1984-11-23 | First Public Issue Date | 2023-08-04 |
| Incorporation Year | 1984 | First Public Issue Year | 2023 |
| Ticker | Concord Bio | ISIN Code | INE338H01029 | |
|---|---|---|---|---|
| Description | Concord Biotech Ltd. | Security Type | Equity Share | |
| Issue Price | 740 | Date Of Issue | 2023-08-11 | |
| Face Value | 1 | Date Of Expiry | ||
| Market Lot | 1 | |||
- Advances - 0
- Declines - 0
- Unchanged - 0
| SYMBOL | Industry | PREV.CLOSE | LTP | CHNG | MarketCap | Weight(%) | Contribution |
|---|
